Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage Activation

Manji, G. A., Stanton, L. J., Hirbe, A. C., Ge, L., Sta Ana, S., Titus, S., Labadie, B. W., May, M. S., Lyu, Y., Chrisinger, J. S. A., Sender, N., Monga, V., Milhem, M., Chugh, R., Sims, P., Tan, A. C., Lee, S., Van Tine, B. A., & Schwartz, G. K. (2025). Phase II Study of Pexidartinib Plus Sirolimus in Unresectable Malignant Peripheral Nerve Sheath Tumors Identifies M2 Macrophage Activation. JCO Oncology Advances, 2. https://doi.org/10.1200/oa-24-00083
Authors:
Gulam A Manji
Liam J Stanton
Angela C Hirbe
Liner Ge
Sarah Sta Ana
Shiny Titus
Brian W Labadie
Michael S May
Yang Lyu
John S A Chrisinger
Naomi Sender
Varun Monga
Mohammed Milhem
Rashmi Chugh
Peter Sims
Aik Choon Tan
Shing Lee
Brian A Van Tine
Gary K Schwartz
Affiliated Authors:
Gulam A Manji
Liam J Stanton
Liner Ge
Sarah Sta Ana
Shiny Titus
Brian W Labadie
Michael S May
Naomi Sender
Peter Sims
Shing Lee
Publication Type:
Article
Unique ID:
10.1200/oa-24-00083
PMID:
Publication Date:
Data Source:
PubMed

Record Created: